infectious diseases and vaccines, Global Clinical Development, Merck Research Laboratories. "This positive opinion is yet another testament to the clinical profile of CAPVAXIVE and brings us a ...

In vaccines, Merck’s pneumococcal disease vaccine Capvaxive was recommended for approval to protect adults from invasive disease and pneumonia caused by streptococcus pneumoniae bacteria.

Merck (MRK) announced that the Committee for Medicinal Products for Human Use, or CHMP, of the European Medicines Agency, or EMA, recommended the approval of capvaxive for active immunization for ...

Merck & Co. said a key European regulatory committee has recommended approval of its Capvaxive pneumococcal disease vaccine designed for adults. Merck on Friday said the recommendation from the ...

He also is pushing back against suggestions that the the lawsuit is "anti-vaccine.” Baum said Merck failed to properly warn patients of potential side effects. In a statement on the civil ...

© 2024 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and ...

Mr. Kennedy has referred clients to the firm in cases claiming injuries from the Gardasil vaccine, a Merck product that is meant to prevent cervical cancer that can be caused by the human ...

RAHWAY, N.J.--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside of the United States and Canada, announced today that the Committee for Medicinal Products for Human Use (CHMP) of the ...

Merck (NYSE: MRK), known as MSD outside of the United States and Canada, announced today that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA ...